Literature DB >> 36262498

Middle Meningeal Artery Embolization: A Paradigm Shift in Approach of Chronic Subdural Hematoma.

Hamza Hanif1,2, Shanza Farook3,2, Sajid S Suriya4,2, Muhammad Umer Riaz Gondal3,2, Muhammad Ibraiz Bilal3,2, Abu Baker Sheikh4,2.   

Abstract

Chronic subdural hematoma (SDH) is commonly seen in the aged population. It is hypothesized to occur due to damage to the dural border cells, resulting in an inflammation-proliferation reaction. Inadequate repair leads to the formation of an external layer of cells and fragile capillaries, which are vulnerable to damage, contributing to worsening of the condition. Conventionally, asymptomatic chronic SDH was managed by observation, while symptomatic cases by surgical evacuation. However, the recurrence rate of chronic SDH after surgical evacuation was high. The middle meningeal artery (MMA) provides blood supply to the dura mater and feeds the capillaries of the membranes covering the SDH. MMA embolization blocks blood flow to this system and promotes hematoma resolution. In this manuscript, we discuss the underlying pathophysiology and current management options for chronic SDH. We also discuss the existing literature on MMA embolization.
© 2022 Greater Baltimore Medical Center.

Entities:  

Keywords:  Chronic; Endovascular; MMA; MMA embolization; SDH

Year:  2022        PMID: 36262498      PMCID: PMC9529640          DOI: 10.55729/2000-9666.1086

Source DB:  PubMed          Journal:  J Community Hosp Intern Med Perspect        ISSN: 2000-9666


  47 in total

1.  Risk Factors Predicting Recurrence of Bilateral Chronic Subdural Hematomas after Initial Bilateral Evacuation.

Authors:  Jun Shen; YaLong Gao; Qifeng Li; Ruixiang Ge; Qifu Wang; XiaoChun Jiang; Xuefei Shao
Journal:  World Neurosurg       Date:  2019-06-14       Impact factor: 2.104

2.  Transradial embolization of the left middle meningeal artery and accessory middle meningeal artery for treatment of subacute-chronic subdural hematoma.

Authors:  Gary B Rajah; Michael K Tso; Rimal Dossani; Kunal Vakharia; Adnan H Siddiqui
Journal:  J Neurointerv Surg       Date:  2020-01-14       Impact factor: 5.836

3.  Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence.

Authors:  Hiroyuki Katano; Ken Kamiya; Mitsuhito Mase; Motoki Tanikawa; Kazuo Yamada
Journal:  J Neurosurg       Date:  2006-01       Impact factor: 5.115

Review 4.  Middle meningeal artery embolization for the management of chronic subdural hematoma.

Authors:  David Fiorella; Adam S Arthur
Journal:  J Neurointerv Surg       Date:  2019-02-23       Impact factor: 5.836

5.  Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations.

Authors:  David Balser; Sameer Farooq; Talha Mehmood; Marleen Reyes; Uzma Samadani
Journal:  J Neurosurg       Date:  2015-03-20       Impact factor: 5.115

6.  Trend in outcome and financial impact of subdural hemorrhage.

Authors:  Jennifer A Frontera; Kenneth de los Reyes; Errol Gordon; Arjun Gowda; Christina Grilo; Natalia Egorova; Aman Patel; Joshua B Bederson
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

7.  Middle meningeal artery embolization for chronic subdural hematoma: Endovascular technique and radiographic findings.

Authors:  Thomas W Link; Benjamin I Rapoport; Stephanie M Paine; Hooman Kamel; Jared Knopman
Journal:  Interv Neuroradiol       Date:  2018-05-02       Impact factor: 1.610

8.  Spontaneous Resolution of Chronic Subdural Hematoma : Close Observation as a Treatment Strategy.

Authors:  Hyung Chan Kim; Jung Ho Ko; Dong Soo Yoo; Sang-Koo Lee
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

Review 9.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.

Authors:  Ellie Edlmann; Susan Giorgi-Coll; Peter C Whitfield; Keri L H Carpenter; Peter J Hutchinson
Journal:  J Neuroinflammation       Date:  2017-05-30       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.